Forte Biosciences, Inc. Common Stock FBRX

$76.83 -0.04% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-12 View →
8-K 8-K 2026-07-27 View →
8-K 8-K 2026-07-09 View →
4 Insider transaction 2026-07-06 View →
4 Insider transaction 2026-07-06 View →
4 Insider transaction 2026-06-17 View →
4 Insider transaction 2026-06-17 View →
4 Insider transaction 2026-06-02 View →
S-3 S-3 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-02 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-14 View →
10-Q 10-Q 2026-05-11 View →
DEF 14A DEF 14A 2026-04-29 View →
424B5 424B5 2026-04-09 View →
8-K 8-K 2026-04-09 View →
424B5 424B5 2026-04-08 View →
4 Insider transaction 2026-04-03 View →
4 Insider transaction 2026-04-03 View →
8-K 8-K 2026-04-01 View →
10-K 10-K 2026-03-31 View →
4 Insider transaction 2026-01-13 View →
4 Insider transaction 2026-01-13 View →
4 Insider transaction 2026-01-02 View →
4 Insider transaction 2026-01-02 View →
10-Q 10-Q 2025-11-14 View →
8-K 8-K 2025-11-14 View →
4 Insider transaction 2025-10-02 View →
4 Insider transaction 2025-10-02 View →
10-Q 10-Q 2025-08-14 View →
8-K 8-K 2025-08-14 View →
4 Insider transaction 2025-07-03 View →
4 Insider transaction 2025-07-03 View →
424B5 424B5 2025-06-25 View →
8-K 8-K 2025-06-25 View →
424B5 424B5 2025-06-24 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$76.83
Market Cap
$1.63 billion
52-Week Range
$9.10 – $77.20
Average Volume
1.94 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.